<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00413348</url>
  </required_header>
  <id_info>
    <org_study_id>probiotics.sa.cim.rh.dk</org_study_id>
    <nct_id>NCT00413348</nct_id>
  </id_info>
  <brief_title>Type 2 Diabetes and the Effect of Probiotics</brief_title>
  <official_title>Effect of Probiotics on Systemic Inflammation and Insulin Resistance in Type 2 Diabetics and Healthy Controls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Royal Veterinary and Agricultural University, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <brief_summary>
    <textblock>
      Insulin-resistance in type 2 diabetes is associated with chronic inflammation.
      Anti-inflammatory actions might increase sensitivity to insulin. Since some probiotics have
      anti-inflammatory properties, ingestion of the probiotic bacteria Lactobacillus Acidophilus
      NCFM might increase insulin-sensitivity.

      The inflammatory response to endotoxin injection and the insulin-sensitivity is examined
      before and after four weeks ingestion of probiotics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Numerous studies have shown an association between insulin-resistance in type 2 diabetes and
      chronic low-grade inflammation. Some probiotics have an anti-inflammatory properties.
      Ingestion of probiotics might therefore, due to this property, increase sensitivity to
      insulin.

      In this study type 2 diabetics (N=24) and healthy control (N=24) are given the probiotic
      bacteria Lactobacillus Acidophilus NCFM for four weeks. The anti-inflammatory effect is
      examined by evaluating the inflammatory response (White blood cell count, plasma-cytokines)
      to an iv injection of endotoxin (0,3 ng/kg) before and after the intervention. Also the
      insulin-sensitivity is measured with an hyperinsulinemic euglycemic clamp before and after L.
      acidophilus NCFM.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2006</start_date>
  <completion_date>December 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in insulin-resistance</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in inflammatory response to E. coli endotoxin injection</measure>
  </primary_outcome>
  <enrollment>48</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Healthy</condition>
  <condition>Endotoxemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactobacillus acidophilus NCFM</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Type 2 diabetes

        Exclusion Criteria:

          -  Heart failure

          -  Lung disease

          -  Infections in the last two weeks before endotoxin injections.

          -  Treatment with antibiotics
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Sofie Andreasen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Sofie Andreasen, MD</last_name>
    <phone>+45 3545 1616</phone>
    <email>sofie_andreasen@msn.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bente K Pedersen, Preofessor</last_name>
    <phone>+45 3545 7797</phone>
    <email>bkp@rh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Center of Inflammation and metabolism 7641 and Intensive Care Unit 4131, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK-2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Anne Sofie Andreasen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2006</study_first_submitted>
  <study_first_submitted_qc>December 18, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2006</study_first_posted>
  <last_update_submitted>December 18, 2006</last_update_submitted>
  <last_update_submitted_qc>December 18, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2006</last_update_posted>
  <keyword>Type 2 diabetes</keyword>
  <keyword>Probiotics</keyword>
  <keyword>Insulin-resistance</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Hyperinsulinemic euglycemic clamp</keyword>
  <keyword>Endotoxin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Endotoxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

